机构:[1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China血液科首都医科大学宣武医院[2]Department of Endocrinology, Second Hospital of Shandong University, Jinan, Shandong 250033, China[3]Department of Endocrinology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250030, China[4]Diabetes Center at Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA
第一作者机构:[1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
通讯作者:
通讯机构:[1]Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
Xia Chang-qing,Liu Yuan-tao,Guan Qing-bo,et al.Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes[J].CHINESE MEDICAL JOURNAL.2013,126(5):957-964.doi:10.3760/cma.j.issn.0366-6999.20122444.
APA:
Xia Chang-qing,Liu Yuan-tao,Guan Qing-bo&Clare-Salzler, Michael.(2013).Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes.CHINESE MEDICAL JOURNAL,126,(5)
MLA:
Xia Chang-qing,et al."Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes".CHINESE MEDICAL JOURNAL 126..5(2013):957-964